Literature DB >> 27369084

Changing Cycle Lengths in State-Transition Models: Challenges and Solutions.

Jagpreet Chhatwal1, Suren Jayasuriya2, Elamin H Elbasha3.   

Abstract

The choice of a cycle length in state-transition models should be determined by the frequency of clinical events and interventions. Sometimes there is need to decrease the cycle length of an existing state-transition model to reduce error in outcomes resulting from discretization of the underlying continuous-time phenomena or to increase the cycle length to gain computational efficiency. Cycle length conversion is also frequently required if a new state-transition model is built using observational data that have a different measurement interval than the model's cycle length. We show that a commonly used method of converting transition probabilities to different cycle lengths is incorrect and can provide imprecise estimates of model outcomes. We present an accurate approach that is based on finding the root of a transition probability matrix using eigendecomposition. We present underlying mathematical challenges of converting cycle length in state-transition models and provide numerical approximation methods when the eigendecomposition method fails. Several examples and analytical proofs show that our approach is more general and leads to more accurate estimates of model outcomes than the commonly used approach. MATLAB codes and a user-friendly online toolkit are made available for the implementation of the proposed methods.
© The Author(s) 2016.

Entities:  

Keywords:  Markov models; cost-effectiveness analysis; decision analysis; global health; mathematical models

Mesh:

Year:  2016        PMID: 27369084      PMCID: PMC5045797          DOI: 10.1177/0272989X16656165

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  21 in total

1.  Estimation of the transition matrix of a discrete-time Markov chain.

Authors:  Bruce A Craig; Peter P Sendi
Journal:  Health Econ       Date:  2002-01       Impact factor: 3.046

2.  Rates and probabilities in economic modelling: transformation, translation and appropriate application.

Authors:  Rachael L Fleurence; Christopher S Hollenbeak
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

Review 3.  Primer on medical decision analysis: Part 1--Getting started.

Authors:  A S Detsky; G Naglie; M D Krahn; D Naimark; D A Redelmeier
Journal:  Med Decis Making       Date:  1997 Apr-Jun       Impact factor: 2.583

4.  Theoretical Foundations and Practical Applications of Within-Cycle Correction Methods.

Authors:  Elamin H Elbasha; Jagpreet Chhatwal
Journal:  Med Decis Making       Date:  2015-06-19       Impact factor: 2.583

5.  Optimal Policies for Reducing Unnecessary Follow-up Mammography Exams in Breast Cancer Diagnosis.

Authors:  Oguzhan Alagoz; Jagpreet Chhatwal; Elizabeth S Burnside
Journal:  Decis Anal       Date:  2013-09

6.  Modelling the cost effectiveness of lamivudine/zidovudine combination therapy in HIV infection.

Authors:  J V Chancellor; A M Hill; C A Sabin; K N Simpson; M Youle
Journal:  Pharmacoeconomics       Date:  1997-07       Impact factor: 4.981

7.  Determining transition probabilities: confusion and suggestions.

Authors:  D K Miller; S M Homan
Journal:  Med Decis Making       Date:  1994 Jan-Mar       Impact factor: 2.583

8.  Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy.

Authors:  Gillian D Sanders; Ahmed M Bayoumi; Vandana Sundaram; S Pinar Bilir; Christopher P Neukermans; Chara E Rydzak; Lena R Douglass; Laura C Lazzeroni; Mark Holodniy; Douglas K Owens
Journal:  N Engl J Med       Date:  2005-02-10       Impact factor: 91.245

9.  Cost-effectiveness and budget impact of hepatitis C virus treatment with sofosbuvir and ledipasvir in the United States.

Authors:  Jagpreet Chhatwal; Fasiha Kanwal; Mark S Roberts; Michael A Dunn
Journal:  Ann Intern Med       Date:  2015-03-17       Impact factor: 25.391

10.  New protease inhibitors for the treatment of chronic hepatitis C: a cost-effectiveness analysis.

Authors:  Shan Liu; Lauren E Cipriano; Mark Holodniy; Douglas K Owens; Jeremy D Goldhaber-Fiebert
Journal:  Ann Intern Med       Date:  2012-02-21       Impact factor: 25.391

View more
  9 in total

Review 1.  Verification of Decision-Analytic Models for Health Economic Evaluations: An Overview.

Authors:  Erik J Dasbach; Elamin H Elbasha
Journal:  Pharmacoeconomics       Date:  2017-07       Impact factor: 4.981

2.  Estimating Long-Term Drinking Patterns for People with Lifetime Alcohol Use Disorder.

Authors:  Carolina Barbosa; William N Dowd; Arnie P Aldridge; Christine Timko; Gary A Zarkin
Journal:  Med Decis Making       Date:  2019-10-03       Impact factor: 2.583

3.  Comparison of Decision Modeling Approaches for Health Technology and Policy Evaluation.

Authors:  John Graves; Shawn Garbett; Zilu Zhou; Jonathan S Schildcrout; Josh Peterson
Journal:  Med Decis Making       Date:  2021-03-18       Impact factor: 2.749

4.  Telemonitoring Versus Usual Care for Elderly Patients With Heart Failure Discharged From the Hospital in the United States: Cost-Effectiveness Analysis.

Authors:  Xinchan Jiang; Jiaqi Yao; Joyce Hs You
Journal:  JMIR Mhealth Uhealth       Date:  2020-07-06       Impact factor: 4.773

Review 5.  Modeling the coronavirus disease 2019 pandemic: A comprehensive guide of infectious disease and decision-analytic models.

Authors:  Stephen Mac; Sharmistha Mishra; Raphael Ximenes; Kali Barrett; Yasin A Khan; David M J Naimark; Beate Sander
Journal:  J Clin Epidemiol       Date:  2020-12-07       Impact factor: 6.437

6.  Cost-effectiveness of internet-supported cognitive behavioral therapy for university students with anxiety symptoms: A Markov-model analysis.

Authors:  Joyce H S You; Scotty W C Luk; Dilys Y W Chow; Xinchan Jiang; Arthur D P Mak; Winnie W S Mak
Journal:  PLoS One       Date:  2022-05-05       Impact factor: 3.240

Review 7.  Current recommendations on the estimation of transition probabilities in Markov cohort models for use in health care decision-making: a targeted literature review.

Authors:  Elena Olariu; Kevin K Cadwell; Elizabeth Hancock; David Trueman; Helene Chevrou-Severac
Journal:  Clinicoecon Outcomes Res       Date:  2017-09-01

8.  Estimating Transition Probabilities from Published Evidence: A Tutorial for Decision Modelers.

Authors:  Risha Gidwani; Louise B Russell
Journal:  Pharmacoeconomics       Date:  2020-11       Impact factor: 4.981

9.  Cost-utility analysis of esketamine and electroconvulsive therapy in adults with treatment-resistant depression.

Authors:  Kinza Degerlund Maldi; Peter Asellus; Anna Myléus; Fredrik Norström
Journal:  BMC Psychiatry       Date:  2021-12-07       Impact factor: 3.630

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.